Publication | Closed Access

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)

Heart FailureEpoprostenol TherapyStructural Heart DiseaseCardiovascular DiseaseControlled TrialCardiovascular PharmacologyPharmacotherapyCardiac CareMedicineCardiologyEmergency Medicine